News
thumbnail
Deal MakingVertex gains renal disease cytokine in $4.9bn Alpine buyVertex gains renal disease cytokine in $4.9bn Alpine buy
Vertex Pharmaceuticals says it will add protein engineering and immunotherapy expertise through the addition of Alpine Immune Sciences.